WallStreetZenWallStreetZen

NASDAQ: ZYXI
Zynex Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ZYXI past earnings growth

How has ZYXI's earnings growth performed historically?
Company
-38.64%
Industry
2.73%
Market
107.64%
ZYXI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ZYXI's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ZYXI's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ZYXI past revenue growth

How has ZYXI's revenue growth performed historically?
Company
16.54%
Industry
10.18%
Market
17.61%
ZYXI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZYXI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZYXI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZYXI earnings and revenue history

Current Revenue
$184.3M
Current Earnings
$9.7M
Current Profit Margin
5.3%

ZYXI Return on Equity

Current Company
16.8%
Current Industry
16.7%
Current Market
188%
ZYXI's Return on Equity (16.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZYXI announces earnings.

ZYXI Return on Assets

Current Company
7.1%
Current Industry
3.5%
ZYXI is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZYXI Return on Capital Employed

Current Company
11.55%
Current Industry
19.4%
ZYXI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZYXI vs Medical Distribution Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZYXI$184.32M$18.80M$9.73M+42.01%+0.45%
EDAP$65.68M-$21.41M-$23.02M+8.31%N/A
AHG$2.20MN/A-$5.63M-54.23%N/A
OMI$10.33B$390.57M-$41.30M+1.87%N/A
PDCO$6.57B$384.69M$193.86M+3.46%+19.70%
View Top Medical Distribution Stocks

ZYXI earnings dates

Next earnings date
Apr 25, 2024

Zynex Earnings & Revenue FAQ

What were ZYXI's earnings last quarter?

On Invalid Date, Zynex (NASDAQ: ZYXI) reported Q4 2023 earnings per share (EPS) of $0.03, up 84.21% year over year. Total Zynex earnings for the quarter were $1.22 million. In the same quarter last year, Zynex's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Zynex stock.

What was ZYXI's earnings growth in the past year?

As of Q2 2024, Zynex's earnings has grown -38.64% year over year. This is 41.37 percentage points lower than the US Medical Distribution industry earnings growth rate of 2.73%. Zynex's earnings in the past year totalled $9.73 million.

What is ZYXI's earnings date?

Zynex's earnings date is Invalid Date. Add ZYXI to your watchlist to be reminded of ZYXI's next earnings announcement.

What was ZYXI's revenue last quarter?

On Invalid Date, Zynex (NASDAQ: ZYXI) reported Q4 2023 revenue of $47.29 million up 3.11% year over year. In the same quarter last year, Zynex's revenue was $48.81 million.

What was ZYXI's revenue growth in the past year?

As of Q2 2024, Zynex's revenue has grown 16.54% year over year. This is 6.36 percentage points higher than the US Medical Distribution industry revenue growth rate of 10.18%. Zynex's revenue in the past year totalled $184.32 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.